BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Medici V, LaSalle JM. Genetics and epigenetic factors of Wilson disease. Ann Transl Med 2019;7:S58. [PMID: 31179295 DOI: 10.21037/atm.2019.01.67] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 4.3] [Reference Citation Analysis]
Number Citing Articles
1 Yuan XZ, Yang RM, Wang XP. Management Perspective of Wilson's Disease: Early Diagnosis and Individualized Therapy. Curr Neuropharmacol 2021;19:465-85. [PMID: 32351182 DOI: 10.2174/1570159X18666200429233517] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
2 Yi F, Poskanzer SA, Myers CT, Thies J, Collins CJ, Dayuha R, Duong P, Houwen R, Hahn SH. p.P1379S, a benign variant with reduced ATP7B protein level in Wilson Disease. JIMD Rep 2020;54:32-6. [PMID: 32685348 DOI: 10.1002/jmd2.12127] [Reference Citation Analysis]
3 Žigrai M, Vyskočil M, Tóthová A, Vereš P, Bluska P, Valkovič P. Late-Onset Wilson's Disease. Front Med (Lausanne) 2020;7:26. [PMID: 32118011 DOI: 10.3389/fmed.2020.00026] [Cited by in Crossref: 5] [Cited by in F6Publishing: 1] [Article Influence: 2.5] [Reference Citation Analysis]
4 Weiskirchen S, Kim P, Weiskirchen R. Laser Ablation Inductively Coupled Plasma Spectrometry: Metal Imaging in Experimental and Clinical Wilson Disease. Inorganics 2019;7:54. [DOI: 10.3390/inorganics7040054] [Cited by in Crossref: 5] [Article Influence: 1.7] [Reference Citation Analysis]
5 Wijayasiri P, Hayre J, Nicholson ES, Kaye P, Wilkes EA, Evans J, Aithal GP, Jones G, Pearce F, Aravinthan AD. Estimating the clinical prevalence of Wilson's disease in the UK. JHEP Rep 2021;3:100329. [PMID: 34381985 DOI: 10.1016/j.jhepr.2021.100329] [Reference Citation Analysis]
6 Petters J, Cimmaruta C, Iwanov K, Chang ML, Völkner C, Knuebel G, Murua Escobar H, Frech MJ, Hermann A, Rolfs A, Lukas J. Generation of induced pluripotent stem cell lines AKOSi002-A and AKOSi003-A from symptomatic female adults with Wilson disease. Stem Cell Res 2020;43:101708. [PMID: 32028086 DOI: 10.1016/j.scr.2020.101708] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 De Fabregues O, Viñas J, Palasí A, Quintana M, Cardona I, Auger C, Vargas V. Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series. Brain Behav 2020;10:e01596. [PMID: 32202078 DOI: 10.1002/brb3.1596] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
8 Schroeder SM, Matsukuma KE, Medici V. Wilson disease and the differential diagnosis of its hepatic manifestations: a narrative review of clinical, laboratory, and liver histological features. Ann Transl Med 2021;9:1394. [PMID: 34733946 DOI: 10.21037/atm-21-2264] [Reference Citation Analysis]
9 Chen J, Jiang Y, Shi H, Peng Y, Fan X, Li C. The molecular mechanisms of copper metabolism and its roles in human diseases. Pflugers Arch 2020;472:1415-29. [PMID: 32506322 DOI: 10.1007/s00424-020-02412-2] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
10 Li M, Ma J, Wang W, Yang X, Luo K. Mutation analysis of the ATP7B gene and genotype-phenotype correlation in Chinese patients with Wilson disease. BMC Gastroenterol 2021;21:339. [PMID: 34470610 DOI: 10.1186/s12876-021-01911-5] [Reference Citation Analysis]
11 Heald CJ, Sarma A, Sachs JR, Zapadka ME, Jewett T, Bunch PM. Practical Genetics for the Neuroradiologist: Adding Value in Neurogenetic Disease. Acad Radiol 2022;29 Suppl 3:S1-S27. [PMID: 33495073 DOI: 10.1016/j.acra.2020.12.021] [Reference Citation Analysis]
12 Liu S, Hu C, Luo Y, Yao K. Genome-wide DNA methylation profiles may reveal new possible epigenetic pathogenesis of sporadic congenital cataract. Epigenomics 2020;12:771-88. [PMID: 32516005 DOI: 10.2217/epi-2019-0254] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
13 Muchenditsi A, Talbot CC Jr, Gottlieb A, Yang H, Kang B, Boronina T, Cole R, Wang L, Dev S, Hamilton JP, Lutsenko S. Systemic deletion of Atp7b modifies the hepatocytes' response to copper overload in the mouse models of Wilson disease. Sci Rep 2021;11:5659. [PMID: 33707579 DOI: 10.1038/s41598-021-84894-3] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
14 Sánchez-Monteagudo A, Ripollés E, Berenguer M, Espinós C. Wilson's Disease: Facing the Challenge of Diagnosing a Rare Disease. Biomedicines 2021;9:1100. [PMID: 34572285 DOI: 10.3390/biomedicines9091100] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
15 Stremmel W, Longerich T, Liere R, Vacata V, van Helden J, Weiskirchen R. Wilson disease — the impact of hyperimmunity on disease activity: A case report. World J Clin Cases 2021; 9(6): 1386-1393 [PMID: 33644206 DOI: 10.12998/wjcc.v9.i6.1386] [Cited by in CrossRef: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Cai X, Deng L, Ma X, Guo Y, Feng Z, Liu M, Guan Y, Huang Y, Deng J, Li H, Sang H, Liu F, Yang X. Altered diversity and composition of gut microbiota in Wilson's disease. Sci Rep 2020;10:21825. [PMID: 33311635 DOI: 10.1038/s41598-020-78988-7] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
17 Pop TL, Grama A, Stefanescu AC, Willheim C, Ferenci P. Acute liver failure with hemolytic anemia in children with Wilson’s disease: Genotype-phenotype correlations? World J Hepatol 2021; 13(10): 1428-1438 [PMID: 34786177 DOI: 10.4254/wjh.v13.i10.1428] [Reference Citation Analysis]
18 Dev S, Kruse RL, Hamilton JP, Lutsenko S. Wilson Disease: Update on Pathophysiology and Treatment. Front Cell Dev Biol 2022;10:871877. [DOI: 10.3389/fcell.2022.871877] [Reference Citation Analysis]